You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 6, December 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (59)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Phase-Shift Balloon Pumping in Medically Refractory Cardiogenic Shock

Results in 27 Patients

Adrian Kantrowitz, MD; Joseph S. Krakauer, MD; Arnold Rosenbaum, MD; Alfred N. Butner, MD; Paul S. Freed, MS; Dov Jaron, PhD

AMA Arch Surg. 1969;99(6):739-743.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Pump failure is considered to be the primary pathophysiologic defect in cardiogenic shock secondary to acute myocardial infarction. Several investigators have reported mortality in 85% to 95% of patients with this syndrome.1-4 In those with cardiogenic shock accompanied by pulmonary edema, the fatality rate was 100% in a series of 241 patients with acute myocardial infarction studied by E. Greif, according to an oral communication with him on Oct 28, 1968. Available pharmacologic therapies which augment myocardial contractility or raise systemic blood pressure also increase the internal work of the heart and, therewith, its oxygen demand. Use of these agents does not appear to be associated with an increased survival rate.

Since June 1967 a mechanical means of circulatory support for patients in refractory cardiogenic shock, the intraaortic phase-shift balloon pump, has been under clinical trial. Our experimental laboratory studies and initial clinical evaluation indicated that balloon pumping effectively . . . [Full Text PDF of this Article]


Author Affiliations

Brooklyn, NY

From the Departments of Surgery, State University of New York Downstate Medical Center and Maimonides Medical Center, Brooklyn, NY.


Footnotes

Submitted for publication Aug 5, 1969.

Read before the 17th scientific meeting of the North American Chapter of the International Cardiovascular Society, New York, July 11, 1969.

Reprint requests to Maimonides Medical Center, Brooklyn, NY (Dr. Kantrowitz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.